Strategic partnerships Stratedigm has recently announced a strategic partnership with Certified Genetool, Inc. to enhance global lab support and distribution. This indicates a receptive channel for co-selling, bundled offerings, or regional expansion opportunities that you can leverage to position complementary products and services.

Upgradeable systems The company emphasizes upgradeable, scalable, and automation-ready flow cytometers with a unified software suite. This presents a sales angle for bundled maintenance contracts, software upgrades, and compatibility extensions with existing lab automation investments.

Cryo-Blue launch Recent product introductions include the Cryo-Blue detector, signaling ongoing innovation and a willingness to expand detection capabilities. Opportunities exist to target labs upgrading instrumentation for higher sensitivity, enabling cross-sell of new detectors or compatible accessories.

Mid-market focus With a small team and revenue under one million, Stratedigm sits adjacent to mid-market buyers who value affordable, durable cytometry solutions and long-term service. This suggests a clear path for value-based sales, education-led campaigns, and scalable service partnerships.

Service-centric value A strong commitment to service contracts and decades-long equipment support highlights a priority on reliability and lifecycle value. Propose expanded service tiers, remote monitoring packages, and training services to drive recurring revenue and customer retention.